Archive for October, 2008

Do I need blogging insurance?

| October 30, 2008 | 0 Comments

Westby Fisher, MD is a cardiologist and fellow physician blogger in Evanston, IL who has been blogging since November 2005 at drwes.blogspot.com.  At the time I started this blog we worked at the same hospital and since then I have relied upon his experience from time to time when it comes to blogging among other […]

Continue Reading

General Data’s Healthcare Blog

| October 29, 2008 | 0 Comments

I received a note from Ralph Moher from General Data as did I suspect most registered participants of APIII prior to the meeting that he would be live blogging from APIII.  I have seen this at other meetings (most notably health 2.0 or informatics related meeting) and have been pleasantly surprised at how well this works and […]

Continue Reading

Pathology Visions 2008 and Pathology 2.0

| October 28, 2008 | 0 Comments

Earlier this week I had the good fortune of having the opportunity to speak at Pathology Visions in San Diego.  This annual meeting strives to bring together attendees from around the world to share best practices and learn about exciting innovations in digital pathology. Pathology Visions features thought leaders and early adopters in the digital […]

Continue Reading

Thoughts on APIII meeting

| October 27, 2008 | 0 Comments

Last week I was fortunate to have the opportunity to speak at APIII in Pittsburgh with one of my colleagues to speak about our interests and projects at Mayo.  The shared session also included a histotechnologist from Massachusetts General on some of their lean processes at hand. My colleague, Dr. Schuyler Sanderson presented his extensive experience […]

Continue Reading

Seven Cytotechnology Education Programs “at Risk”

| October 26, 2008 | 0 Comments

Seven of the 39 accredited cytotechnology education programs in the U.S. have been identified as “at risk” for closure, representing a significant public health threat and underscoring the need for additional program funding in the wake of budgetary cutbacks. The at-risk programs, identified in collaboration with the American Society of Cytopathology and state associations across […]

Continue Reading

BJC Study Identifies New Approach to Treating Cancer

| October 23, 2008 | 1 Comment

This is exciting news – finding the cells that matter… Look for more to come on this! Last week Ikonisys announced positive results from a clinical study conducted by the Weatherall Institute of Molecular Medicine at Oxford University, validating the company’s CellOptics® platform and proprietary digital microscope, the Ikoniscope®, as a viable method for quickly […]

Continue Reading

Fewer colonoscopies and biopsies to come…

| October 22, 2008 | 3 Comments

There are a number of clinical investigators exploring the use of non-invasive or minimally invasive technologies to scree for colon cancer that I have posted about in the past.  Another study has been published from here looking at DNA in stool samples recently presented at a large national meeting and published in the medical literature.  […]

Continue Reading

State Department forms telemedicine public-private partnership to improve Pakistan healthcare

| October 21, 2008 | 0 Comments

The US State Department has formed a telemedicine public-private partnership in Pakistan, demonstrating the transformative power of high speed connectivity in improving social services in remote areas.  Telemedicine enables healthcare providers to deliver high quality medical services for patients in remote locations – services that would otherwise be lacking or absent.  The public-private partnership is […]

Continue Reading

Israel’s ASI gives pathologists a vital second opinion

| October 21, 2008 | 0 Comments

Check out this interesting story out of Israel using spectral imaging for improved diagnostics: "You won’t find many professionals in the field admitting it, but the awful truth is that pathology is not an exact science, and mistakes are made – too many mistakes, according to Limor Shiposh, CEO of Migdal Ha’emek’s Applied Spectral Imaging […]

Continue Reading

Why A Mining Company Sends Its Workers to Fancy, Far-Flung Hospitals

| October 20, 2008 | 0 Comments

The WSJ Health Blog has an interesting post about companies sending their employees to referral centers, regardless of cost but weighing benefits of rankings and quality of care.  As the story describes, there are a growing number of references that allow patients and insurers alike greater transparency about expected costs of stays and procedures and […]

Continue Reading

Telemedicine to Receive Financial Boost

| October 19, 2008 | 0 Comments

The Minneapolis Star-Tribune reports on the growth of telemedicine. The Mayo Clinic, for example, is getting into the act. "The technology for telemedicine has been around for years, but there has been a catch: Insurers wouldn’t pay for its use. They paid for visits to a doctor’s office. Now that’s changing, so more patients are […]

Continue Reading

| October 18, 2008 | 0 Comments

In case you follow this market and missed this in the past few days – news from BioImagene.  This was discussed and rumored for some months and with previous news about Siemens executive joining BioImagene not too unexpected.  No dollar amount on the press releases I saw but fair to say even a conservative amount […]

Continue Reading

Is image sharing “social networking” that should be blocked?

| October 16, 2008 | 4 Comments

An increasing number of pathologists share images for illustration and/or query "What is your diagnosis?" on cases whether for help or other thoughts or as unknowns once a case has been worked up and diagnosed.  These include sites such as Flickr, Photobucket and others.  One in particular I check out from time to time is […]

Continue Reading

Role in HER2 in gastric cancer

| October 15, 2008 | 0 Comments

Gastric cancer is the second leading cause of cancer mortality in the world and its management, especially in advanced stages, has evolved relatively little. In particular, no targeted modality has so far been incorporated to its treatment armamentarium. HER2 overexpression is increasingly recognized as a frequent molecular abnormality, driven as in breast cancer by gene […]

Continue Reading